Cellix Ltd logo

Cellix Ltd

Contact Details

Skip to Navigation |  Skip to Content |  Skip to Login
Start of page content
Back to Navigation

University of Aberdeen

 
Cellix, in collaboration with Dr. Helen Galley and Dr. Damon Lowes Department of Medicine Therapeutics, University of Aberdeen, undertook an investigation of T-cell adhesion to ICAM-1 with a mixed sepsis model due to the increasingly frequent and acute medical problem in critically ill patients in the intensive care unit despite significant advances in management and treatment.

Objectives

Investigatin of T-cell adhesion to ICAM-1 using a mixed sepsis model treated with a range of statins (pravastatin, fluvastatin, mevastatin, lovastatin, simvastatin) under physiological shear stress using Cellix  Products.

Equipment Used

Results

LPS/PEPG stimulated cells treated with all statins used in the study caused a statistically significant reduction in adhesion when compared to the LPS/PegP stimulated control.  However, simvastatin treated cells nearly always tended to aggregate even at pM concentrations. 
     
For more detailed analysis please click on the Immunology Application Note - Statins -Sepsis I100

Acknowledgements

Cellix would like to thank Dr. Helen Galley and Dr. Damon Lowes, Department of Medicine Therapeutics, Institute of Medical Sciences, University of Aberdeen, Scotland for their experimental design and time throughout this collaboration.


Register/Login

Not Registered? Sign Up Now

Register for My Cellix

Bottom Navigation